Business Description
XORTX Therapeutics is a Canadian drug development company focused on treating conditions caused by high uric acid levels in the body. Based in Calgary, the company has several medicines in various stages of testing, targeting serious kidney and joint conditions such as gout, polycystic kidney disease, diabetes-related kidney damage, and kidney injury linked to viral infections. Its most advanced treatment is currently in Phase III trials for gout, while other programs range from early research to Phase II clinical studies.
